Stock Market

Pfizer Stock: Long-Term Potential and Investment Strategy

By Bullbit Editorial · March 30, 2026

WhatPfizer lags behind Eli Lilly and Novo Nordisk in the GLP-1 race.
WhyInvestors shouldn't count Pfizer out for long-term gains.
SignalPfizer's GLP-1 pipeline shows promise despite current setbacks.
TargetPfizer's stock price could increase significantly in the next few years.
RiskInvestors should be aware of the potential risks and challenges in the pharmaceutical industry.